Astellas and Roche Diabetes Care Japan Ink Partnership Agreement to Develop and Commercialize Integrated Diabetes Self-management Solution with BlueStar®
– Accu-Chek® Guide Me glucose meter to be paired with BlueStar® in Japan, which is being jointly developed by Astellas and Welldoc – – Initiation of clinical trial planned for fiscal year …
Welldoc Earns 2023 BIG Artificial Intelligence Excellence Award
Columbia, MD, – March, 23, 2023 — Welldoc®, a digital health leader revolutionizing chronic care, today announced that it has been named a winner in the 2023 Artificial Intelligence Excellence Awards program presented …
Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances
Welldoc’s President and CEO, Kevin McRaith, is quoted in the “Scrip Asks” column, which highlights perspectives from corporate leaders on what 2023 holds therapeutic advances in the biopharma industry.
Welldoc Earns 2023 BIG Innovation Award
Columbia, MD, – January 11, 2023 — Welldoc®, a digital health leader revolutionizing chronic care, today announced that it has been named a winner in the 2023 BIG Innovation Awards presented by the …
Welldoc Chief Analytics Officer Anand Iyer, PhD, MBA Receives Global Innovator Award at International Summit Focused on Digital Health
Columbia, MD, – November 3, 2022 — Welldoc®, a digital health leader revolutionizing chronic care, today announced that Anand Iyer, PhD, MBA, Chief Analytics Officer of Welldoc, was recognized with the Global Innovator …
CCS Announces Innovative Partnership with Welldoc and ZeOmega Aimed at Helping People with Chronic Conditions Lead Healthier Lives while Reducing Healthcare Costs
Proprietary collaboration will advance a data-driven, personalized approach to chronic care management for individuals utilizing CCS’s LivingConnected® Solution DALLAS, October 13, 2022 — CCS — leading provider of clinical solutions and home-delivered medical …
